• Qianqian Wang, Junli Yang, Zhigang Guo, and Dan Xi.
• Department of Intensive Care Unit, Nanfang Hospital, Southern Medical University, Guangzhou 510515, People's Republic of China; Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou 510515, People's Republic of China.
• Am. J. Med. Sci. 2024 Nov 1; 368 (5): 424431424-431.

AbstractThe prognosis holds significant implications for the long-term quality of life among patients suffering from coronary artery disease. However, a pressing challenge lies in the absence of reliable biomarkers that can establish a definitive correlation between these biomarkers and the prognosis of coronary artery heart disease. This review paper delves into the critical role of neutrophil gelatinase-associated lipocalin (NGAL) in predicting outcomes in coronary artery disease. It examines the influence of NGAL on various clinical manifestations, including stable angina, ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and isolated coronary artery dilation. Furthermore, this review provides recommendations aimed at enhancing the rigor and impact of future research, thereby serving as a valuable reference for subsequent studies in this domain.Copyright © 2024. Published by Elsevier Inc.

14 keywords...

hide…